ZLZhiqiang Liu

Zhiqiang Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhiqiang Liu has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Jianhui Shangguan

    The Second Department of Neurology Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College Nanchang Jiangxi China

    1 shared publication
  • Jianle He

    The Second Department of Neurology Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College Nanchang Jiangxi China

    1 shared publication
  • Lingxia Jiang

    The Second Department of Neurology Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College Nanchang Jiangxi China

    1 shared publication
  • Min He

    The Second Department of Neurology Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College Nanchang Jiangxi China

    1 shared publication
  • Ping Yang

    The Second Department of Neurology Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College Nanchang Jiangxi China

    1 shared publication

Latest Publications

  • Open Access

    Activation of SIRT1 by Hydroxysafflor Yellow A Attenuates Chronic Unpredictable Mild Stress‐Induced Microglia Activation and Iron Death in Depressed Rats

    by Jianle He, Min He, Ping Yang, Jianhui Shangguan, Lingxia Jiang, Zhiqiang Liu

    Background: Hydroxysafflor yellow A (HSYA), the main active ingredient in safflower, possesses antioxidant and anti‐inflammatory activities. We confirmed in our previous study that HSYA exerts antidepressant effects, but further investigation is needed to uncover the exact mechanism. Herein, we aimed to explore the antidepressant effects of HSYA based on microglial activation and ferroptosis studies.Methods: The chronic unpredictable mild stress (CUMS) procedure was used to establish a depression model in rats. Behavioral tests were conducted on rats after HSYA administration. Iba‐1 immunostaining was used to determine the activation of microglia in the hippocampus. We examined the iron ion level using a colorimetric method. Assayed by western blot for protein expression.Results: Rats receiving HSYA showed enhanced spatial learning and memory abilities, as well as improvements in depression‐like behaviors. HSYA administration reduced Iba‐1 expression in CUMS rats’ hippocampus, indicating that HSYA suppressed microglial activation. HSYA inhibited CUMS‐induced Fe2+ concentration and promoted ferroptosis‐related protein GPX4 and SLC7A11 expression. HSYA treatment also elevated SIRT1 and Nrf2 protein levels, while p‐p65 protein levels decreased in the hippocampus of CUMS rats.Conclusion: HSYA exerts an antidepressant‐like effect by inhibiting microglia activation in the hippocampus and inducing SIRT1/Nrf2/NF‐kB signaling.